Tatalaksana Gangguan Afektif Bipolar pada Ibu Hamil
DOI:
https://doi.org/10.55175/cdk.v46i1.524Kata Kunci:
Gangguan bipolar, kehamilan, penatalaksanaanAbstrak
Sekitar 25%-30% pasien gangguan bipolar yang hamil gejalanya menjadi lebih berat. Gangguan jiwa pada periode perinatal dapat menyebabkan distres signifikan, dapat mengganggu perkembangan ibu dan anak, dan jangka panjang mempengaruhi kesejahteraan ibu, bayi, keluarganya, dan masyarakat luas. Dokter seyogyanya memiliki pengetahuan lebih mengenai tatalaksana komprehensif gangguan bipolar selama kehamilan.
Around 25-30% bipolar disorder patients show worsening symptoms during pregnancy. Mental disorders in perinatal period can cause significant distress that will interfere maternal and child development, and the long-term implication can affect the mother, infant, family, and community. Doctors should have more knowledge on comprehensive management of bipolar disorder during pregnancy.
Unduhan
Referensi
daCosta SC, Passos IC, Lowri C, Soares JC, Kapczinski F. Refractory bipolar disorder and neuroprogression. Prog Neuro-Psychopharmacol Biol Psychiatr. 2016;70:103-10.
Doyle K, Heron J, Berrisford G, Whitmore J, Jones L, Wainscott G, et al. The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse. Eur. Psychiatr. 2012;27:563-9
Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, Baldessarini RJ. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatr. 2011;168:1179-85
Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar. Jakarta: Kementrian Kesehatan RI; 2013
Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin. 2004;20:139–54
Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: Prospective study of mood stabilizer discontinuation. Am J Psychiatr. 2007;164(12):1817–24
Stedman C, Curtis V. Management of bipolar affective disorder during pregnancy. Prog Neurol Psychiatr. 2008;12(7):5–10
Hyman J, Newport DJ. Management of bipolar disorder during pregnancy and lactation. Bipolar B Hist Neurobiol Treatment. 2015;III(2):531–44
Salvatore G. Antipsychotic therapy during early and late pregnancy: A systematic review. Schizophrenia Bull 2010;36(3):518–44
Curtis V. Women are not the same as men: Specific clinical issues for female patients with bipolar disorder. Bipolar Disord. 2005;7(Suppl 1):16–24
Amsterdam JD, Brunswick DJ, O’Reardon J. Bipolar disorder in women. Psychiatr Ann. 2002;32(Suppl 2):397–404
National Institute for Health and Care Excellence. Antenatal and postnatal mental health: Clinical management and service guidance. NICE guidelines. February, 2007.
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study. Lancet Neurol. 2013;12:244–52
Jones I, Chandra PS, Dazzan P, Howard LM. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet 2014;384:1792-93
Dolk H, Wang H, Loane M, Morris J, Garne E, Claude M. Lamotrigine use in pregnancy and risk of orofacial cleft risk, an update. Pharmacoepidemiol Drug Saf. 2012;21(suppl. 3):321
Einarson A , Wood WA , et al. Lithium. In: Exposure to Psychotropic Medications and Other Substances During Pregnancy and Lactation.: Centre for Addiction and Mental Health. 2007. pp. 85–88.
Rusner M, Berg M, Begley C. Bipolar disorder in pregnancy and childbirth: A systematic review of outcomes. BMC Pregnancy Childbirth [Internet]. 2016;16(1):331.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for mood and anxiety treatments (CANMAT) and International Society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170. doi: 10.1111/bdi.12609.
Scrandis DA. Bipolar disorder in pregnancy: A review of pregnancy outcomes. J Midwifery Womens Health. 2017;62(6):673-83. doi: 10.1111/jmwh.12645.
Miller L. Psychopharmacology during pregnancy and breast feeding. From 9th Annual U.S. Psychiatric and Mental Health Congress. 2010.
Wende W. Lithium in pregnancy & lactation—safer than we thought? Mental Health Clinician 2012;2(1):8-9
Grover S, Avasthi A. Mood stabilizers in pregnancy and lactation. Indian J Psychiatr. 2015;57(Suppl S2):308-23
Burt VK, Bernstein C, Rosenstein WS, Altshuler LL. Bipolar disorder and pregnancy: Maintaining psychiatric stability in the real world of obstetric and psychiatric complications. Am J Psychiatr. 2010;167(ein8):892–7
Newport DJ, Viguera AC, Beach AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: Implications for clinical management during late pregnancy. Am J Psychiatr. 2005;162:2162-70
American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemical agents into human milk. Pediatrics 2001;108:776-89
Johannessen S, Johannessen Landmark C. Antiepileptic drug interactions - Principles and clinical implications. Curr Neuropharmacol. 2010;8(3):254–67
Kazmin A, Wong R, Sermer M. Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn. Can Fam Physician. 2010;56(12):1291–92
Epstein RA, Moore KM, Bobo WV. Treatment of bipolar disorders during pregnancy: Maternal and fetal safety and challenges. Drug Healthc Patient Saf. 2014;7:7-29.
Shor S, Koren G, Nulman I. Teratogenicity of lamotrigine. Can Fam Physician. 2007;53(6):1007–9
Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77:193-8
Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36:518–44
Vajda F, O’Brien T. Valproic acid use in pregnancy and congenital malformations. N Engl J Med. 2010;363(18):1771–2.
Choi L, Joo SH, Jeong JH. Olanzapine use in a manic patient during second and third trimester pregnancy. Neuropsychiatr Dis Treat. 2014;10:325–8.
Koren G, Nava-Ocampo AA, Moretti ME, Sussman R, Nulman I. Major malformations with valproic acid. Can Fam Physician. 2006;52(4):441–7.
Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. NEAD study group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study. Lancet Neurol. 2013;12(3):244–52.
Xiu S, Poo W, Agius M. Atypical antipsychotics for schizophrenia and/or bipolar disorder in pregnancy: Current recommendations and updates in the nice guidelines. Psychiatr Danub. 2015;27:255–60.
Özdemir AK, Pak ŞC, Canan F, Geçici Ö, Kuloğlu M, Gücer MK. Paliperidone palmitate use in pregnancy in a woman with schizophrenia. Arch Womens Ment Health. 2015;18(5):739–40.
Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. a systematic review. Basic Clin Pharmacol Toxicol. 2015;116(4):315–20.
Boden R, Lundgren M, Brandt L, Reutfors J, Kieler H. (2012) Antipsychotics During pregnancy: Relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 2012;69: 715–21.
Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378:1306–15.
Marsh W, Viguera A. Bipolar disorder through pregnancy and postpartum. Psychiatr Ann. 2012;42(May):184–9.
Reis M, Kallen B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28: 279–88
Guloksuz S, Akdeniz F, Ince B, Oral ET. The treatment of bipolar disorder during pregnancy and the postpartum period. Turk Psikiyatr Derg. 2010;21(2):155–66
Sienaert P, Lambrichts L, Dols A, De FJ. Evidence-based treatment strategies for treatment-resistant bipolar depression: A systematic review. Bipolar Disord. 2013;15:61–9
Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Høie B. Electroconvulsive therapy during pregnancy: A systematic review of case studies. Arch Womens Ment Health. 2015;18(1):1–39.
Anderson EL, Reti IM. ECT in pregnancy: A review of the literature from 1941 to 2007. Psychosom Med. 2009;71:235–42
Ray-Griffith SL, Coker JL, Rabie N, Eads LA, Golden KJ, Stowe ZN. Pregnancy and electroconvulsive therapy a multidisciplinary approach. J ECT. 2016;32(2):104–12.
Yonkers K, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatr. 2004;161(4):608–20
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2019 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
